# Zahi Touma

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zahi-touma/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,539 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 45 |
| i10-index | 132 |
| Last Known Institution | University Health Network |
| OpenAlex ID | https://openalex.org/A5003819915 |
| ORCID iD | 0000-0001-5177-2076 |
| Works | 392 |

## Researcher papers

- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Systemic lupus erythematosus](https://scholariq.org/papers/systemic-lupus-erythematosus-4/)
- [Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study](https://scholariq.org/papers/efficacy-and-safety-of-ustekinumab-an-il-12-and-il-23-inhibitor-in-patients-with/)
- [Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta‐Analysis of Observational Studies](https://scholariq.org/papers/risk-of-cardiovascular-morbidity-in-patients-with-psoriatic-arthritis-a-meta/)
- [Apoptotic cell–induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans](https://scholariq.org/papers/apoptotic-cell-induced-ahr-activity-is-required-for-immunological-tolerance-and/)
- [Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis](https://scholariq.org/papers/prevalence-and-metric-of-depression-and-anxiety-in-systemic-lupus-erythematosus/)
- [What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis](https://scholariq.org/papers/what-is-the-prevalence-of-cognitive-impairment-in-lupus-and-which-instruments/)
- [SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation](https://scholariq.org/papers/sledai-2k-10-days-versus-sledai-2k-30-days-in-a-longitudinal-evaluation/)
- [Mycophenolate Mofetil for Induction Treatment of Lupus Nephritis: A Systematic Review and Metaanalysis](https://scholariq.org/papers/mycophenolate-mofetil-for-induction-treatment-of-lupus-nephritis-a-systematic/)
- [Responsive and monophasic lupus nephritis: prevalence, associations and outcomes](https://scholariq.org/papers/responsive-and-monophasic-lupus-nephritis-prevalence-associations-and-outcomes/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Researcher university

- [University Health Network](https://scholariq.org/institutions/university-health-network/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.